Summary of Purpose
The aim of the study is to determine if single-bolus recombinant nonimmunogenic staphylokinase is effective and save thrombolytic agent in with ischemic stroke in comparison to alteplase.Read More →
The following dates are available for this trial. Trial information last updated on 11 May 2017.
|15 Jul 2016||10 May 2017||27 Dec 2018||27 Dec 2018||1 May 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Supergene, LLC Lead
- Evgenii I Gusev, MD, Prof